BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 21802580)

  • 1. Implementing cardiovascular risk reduction in patients with cardiovascular disease and diabetes mellitus.
    Nandish S; Wyatt J; Bailon O; Smith M; Oliveros R; Chilton R
    Am J Cardiol; 2011 Aug; 108(3 Suppl):42B-51B. PubMed ID: 21802580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic endovascular disease: role of coronary artery revascularization.
    Stone KE; Chiquette E; Chilton RJ
    Am J Cardiol; 2007 Feb; 99(4A):105B-112B. PubMed ID: 17307063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diabetes and ischemic heart disease: specific treatment].
    Raddino R; Bonadei I; Teli M; Robba D; Caretta G; Madureri A; Zanini G; Pedrinazzi C; Vizzardi E; Cas LD
    G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):52S-55S. PubMed ID: 19195307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should we prescribe statin and aspirin for every diabetic patient? Is it time for a polypill?
    Wienbergen H; Senges J; Gitt AK
    Diabetes Care; 2008 Feb; 31 Suppl 2():S222-5. PubMed ID: 18227489
    [No Abstract]   [Full Text] [Related]  

  • 5. Primary prevention of cardiovascular disease in people with dysglycemia.
    Bianchi C; Miccoli R; Penno G; Del Prato S
    Diabetes Care; 2008 Feb; 31 Suppl 2():S208-14. PubMed ID: 18227487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for coronary artery disease in patients with diabetes.
    Bax JJ; Young LH; Frye RL; Bonow RO; Steinberg HO; Barrett EJ;
    Diabetes Care; 2007 Oct; 30(10):2729-36. PubMed ID: 17901530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin for primary prevention of cardiovascular events in patients with diabetes: A meta-analysis.
    Zhang C; Sun A; Zhang P; Wu C; Zhang S; Fu M; Wang K; Zou Y; Ge J
    Diabetes Res Clin Pract; 2010 Feb; 87(2):211-8. PubMed ID: 19853947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ischemic heart disease].
    Ohsaka H; Kiyanagi T; Daida H
    Nihon Rinsho; 2010 May; 68(5):911-9. PubMed ID: 20446592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 2 diabetes: one disease, multiple cardiovascular risk factors.
    Calles-Escandon J; Garcia-Rubi E; Mirza S; Mortensen A
    Coron Artery Dis; 1999; 10(1):23-30. PubMed ID: 10196684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Type 2 diabetes mellitus and cardiovascular diseases: evaluation, treatment and prevention strategies].
    Mosseri MM; Fisman EZ; Tenenbaum A
    Harefuah; 2006 Feb; 145(2):141-6, 164. PubMed ID: 16509421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of silent coronary artery disease in type 2 diabetes.
    Zellweger MJ
    Herz; 2006 May; 31(3):240-5. PubMed ID: 16770561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of clopidogrel and aspirin in combination versus aspirin alone on platelet activation and major receptor expression in diabetic patients: the PLavix Use for Treatment Of Diabetes (PLUTO-Diabetes) trial.
    Serebruany VL; Malinin AI; Pokov A; Barsness G; Hanley DF
    Am Heart J; 2008 Jan; 155(1):93.e1-7. PubMed ID: 18082496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of coronary artery calcium screening in subjects with and without diabetes.
    Raggi P; Shaw LJ; Berman DS; Callister TQ
    J Am Coll Cardiol; 2004 May; 43(9):1663-9. PubMed ID: 15120828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced platelet response to aspirin in patients with coronary artery disease and type 2 diabetes mellitus.
    Mortensen SB; Larsen SB; Grove EL; Kristensen SD; Hvas AM
    Thromb Res; 2010 Oct; 126(4):e318-22. PubMed ID: 20451957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From pathophysiology to targeted therapy for atherothrombosis: a role for the combination of statin and aspirin in secondary prevention.
    Chapman MJ
    Pharmacol Ther; 2007 Jan; 113(1):184-96. PubMed ID: 17070923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current perspective. Diabetic vascular disease: from endothelial dysfunction to atherosclerosis.
    Candido R; Zanetti M
    Ital Heart J; 2005 Sep; 6(9):703-20. PubMed ID: 16212072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased cardiovascular risk associated with diabetes in Dallas County.
    Das SR; Vaeth PA; Stanek HG; de Lemos JA; Dobbins RL; McGuire DK
    Am Heart J; 2006 May; 151(5):1087-93. PubMed ID: 16644340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes mellitus: a cardiovascular disease.
    Candido R; Srivastava P; Cooper ME; Burrell LM
    Curr Opin Investig Drugs; 2003 Sep; 4(9):1088-94. PubMed ID: 14582453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of diabetes mellitus on long-term survival in systematic off-pump coronary artery bypass surgery.
    Marcheix B; Vanden Eynden F; Demers P; Bouchard D; Cartier R
    Ann Thorac Surg; 2008 Oct; 86(4):1181-8. PubMed ID: 18805157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials.
    Saha SA; Molnar J; Arora RR
    Diabetes Obes Metab; 2008 Jan; 10(1):41-52. PubMed ID: 18095949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.